Trial NCT03241810

View at ClinicalTrials.gov 
Org. Study IDs: MM-121-02-02-10
Secondary IDs: 2017-000565-76

Last trial update was posted on 2020-09-02

MeSH Interventions

Fulvestrant

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

Merrimack Inc. terminated the trial early due to business decision

Limitations And Caveats

Sponsor (Merrimack Pharmaceuticals, INC.) terminated the trial early due to business decision

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID